Tassani P, Martin K, Jänicke U, Ott E
Institute of Anesthesiology, University of Munich, Grosshadern Medical Center, Germany.
J Cardiothorac Vasc Anesth. 1997 Aug;11(5):562-4. doi: 10.1016/s1053-0770(97)90004-5.
To discover possible effects on systemic vascular resistance of the anesthetic induction agent eltanolone in comparison with thiopental and etomidate. The measurements were performed during cardiopulmonary bypass to maintain a constant cardiac output (approximately pump flow).
The patients were prospectively randomized in three groups to receive either eltanolone, thiopental, or etomidate.
University hospital as a single center.
Seventy-five patients scheduled for elective coronary artery bypass grafting.
The anesthetic induction agents were repeated at the same dosage when cardiopulmonary bypass was instituted. The respective mean dosages were eltanolone, 0.41 +/- 0.1 mg/kg; thiopental, 2.88 +/- 0.62 mg/kg; etomidate, 0.26 +/- 0.06 mg/kg.
Systemic vascular resistance was calculated from the mean of a triple measurement (normal pump flow and +/- 20%). Points of measurement were before, and 2 and 5 minutes after injection of the hypnotic agent. None of the injected drugs made a significant change in the systemic vascular resistance. A small (not significant) decrease from 1,295 +/- 296 dyne/s/cm-5 to 1,196 +/- 323 dyne/s/cm-5 (mean +/- SD) was seen in the eltanolone group, whereas the other patients did not show any change during the study period.
The reason for the significant reduction of the arterial pressure attributed to anesthetic induction by eltanolone may be more a cardiodepressive effect than a direct vasodilation.
比较麻醉诱导剂埃他诺龙与硫喷妥钠和依托咪酯对体循环血管阻力的可能影响。测量在体外循环期间进行,以维持恒定的心输出量(约泵流量)。
患者被前瞻性地随机分为三组,分别接受埃他诺龙、硫喷妥钠或依托咪酯。
大学医院作为单一中心。
75例计划进行择期冠状动脉旁路移植术的患者。
在建立体外循环时,以相同剂量重复使用麻醉诱导剂。各自的平均剂量为:埃他诺龙,0.41±0.1mg/kg;硫喷妥钠,2.88±0.62mg/kg;依托咪酯,0.26±0.06mg/kg。
体循环血管阻力由三次测量的平均值计算得出(正常泵流量及±20%)。测量点为注射催眠药前、注射后2分钟和5分钟。所注射的药物均未使体循环血管阻力发生显著变化。埃他诺龙组出现了从1295±296达因·秒/厘米⁻⁵至1196±323达因·秒/厘米⁻⁵的小幅(不显著)下降,而其他患者在研究期间未显示任何变化。
埃他诺龙麻醉诱导导致动脉压显著降低的原因可能更多是心脏抑制作用而非直接血管舒张作用。